ARS Pharmaceuticals, Inc.
ARS Pharmaceuticals commercializes neffy, an epinephrine nasal spray for emergency treatment of anaphylaxis in adults and pediatric patients in the United States and Europe.
10-QAug 13Latest SEC filing, period to Jun 30
Aug 13Latest story